The LIFR gene gives cells instructions for a receptor that passes signals important for bone growth, nerve function, and how the body handles stress. If this gene does not work properly, especially when both copies carry a pathogenic variant, it can cause Stüve-Wiedemann syndrome, a rare condition that affects bone shape and can lead to feeding, breathing, and body temperature problems in infancy. LIFR is mainly recognized in rare disease genetics rather than in popular culture.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which do much of the work inside cells. Others mainly control when certain processes happen, where they take place, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
LIFRGene function
What if the gene works
The LIFR gene helps cells receive growth and development signals. This supports bone growth, nerve function, and the healthy development of several organs before and after birth.
Risk
What if the gene does not work
More severe variants in the LIFR gene can cause Stüve-Wiedemann syndrome, a condition affecting bone growth and the automatic body functions that control breathing, feeding, and temperature. Milder variants may lead to later onset or a less marked pattern.
Treatment
What does that mean for your treatment
No LIFR-specific treatment or drug choice is currently established for pathogenic or loss-of-function variants in the LIFR gene; care is supportive and guided by symptoms. The LIFR gene is also being studied in cancer research as a possible biomarker and treatment target.
Conditions associated with LIFR
Gene function
What if the gene works
The LIFR gene helps cells pick up important chemical messages from their surroundings. It is involved in signals that guide growth, cell maturation, and everyday cell survival. Understanding how the LIFR gene helps cells receive growth signals makes its role easier to picture in developing and healthy tissues.
The LIFR gene makes part of a docking site on the cell surface for several messenger proteins. When one of these messengers binds, the receptor passes the message inward so the cell can adjust its activity.
These signals help cells decide when to grow, mature, or keep their usual job. This matters during early development and in the ongoing upkeep of many tissues.
LIFR signaling can help cells stay steady during everyday stress and supports cell survival. Many tissues use this pathway to keep routine functions balanced as conditions change.
This signaling pathway is especially important in the developing skeleton and nervous system. It helps guide normal tissue formation and supports healthy communication between cells as these systems mature.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help account for normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change the function of a gene more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
How variants influence the LIFR gene's function depends on how much they disrupt the receptor protein. More severe variants, such as those that truncate the protein, often leave little or no working receptor, while some missense variants may allow partial signaling or make the protein less stable. In LIFR-related disease, this range can influence how early features appear and how marked they are, including effects on bone development and body control signals.
How variants are linked to conditions
Pathogenic variants in the LIFR gene cause Stüve-Wiedemann syndrome, a rare inherited condition affecting bone growth and body functions such as breathing and temperature control. When people look at how variants in the LIFR gene are linked to conditions, this is the main confirmed association. Babies with this diagnosis may have bowed long bones, short stature, feeding or breathing problems, and episodes of overheating. It was historically called Schwartz-Jampel syndrome type 2.
A variant is not necessarily a diagnosis
Genetic variants are a natural part of being human, and they are widespread in the general population. Most do not have a direct effect on health and simply contribute to normal human variation. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For LIFR, risk is mainly shaped by inheritance: a child is affected when they inherit two changed copies of the gene, one from each parent. The chance is higher in families where both parents carry a LIFR variant, including some families with close blood relatives. Lifestyle habits do not meaningfully change the chance of having this condition.
Inheritance of LIFR variants
For families trying to understand how LIFR gene variants are inherited, the best established pattern is autosomal recessive. This means a child usually inherits one LIFR gene variant from each parent, and the parents are often healthy carriers. When both parents carry a disease-causing variant in the LIFR gene, each pregnancy has a 25% chance of being affected, a 50% chance of resulting in a carrier child, and a 25% chance of inheriting neither variant. Because the LIFR gene is on chromosome 5, this pattern is the same for males and females.
What does my LIFR result mean for my family?
For families with a disease-causing change in the LIFR gene, the pattern is usually recessive, which means parents are often healthy carriers. Brothers and sisters may also be carriers, and in some families a sibling could also be affected. Other relatives, such as adult brothers, sisters, or cousins, may want to learn whether the change runs in the family, especially when planning children.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the LIFR gene usually looks at DNA from a blood sample or saliva sample. A lab reads the gene’s code, often by sequencing, and may also check for missing or extra pieces, which can help confirm a diagnosis in people with features of Stüve-Wiedemann syndrome.
When should I consider getting a genetic test?
Consider testing the LIFR gene if a baby or child has signs of Stüve-Wiedemann syndrome, such as severe bone growth problems, feeding trouble, repeated overheating, or trouble controlling body temperature. Testing may also help when this condition runs in the family or when parents want to clarify the chance for a future pregnancy.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they explain varies by the condition and the kind of variant involved. Over time, the body is also shaped by factors such as lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, these results can also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug faster or slower than expected, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person, do little for another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medicines. It looks at links between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medications, genes can affect how strongly a drug works or how the body handles it. This information can support treatment decisions that are better informed and more individualized. If you want to read more about this topic, you can find additional information in the LearnHub.
Drugs influenced by the LIFR gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dosing, so questions about medicines, side effects, or your overall health are best discussed with your doctor.
History
The LIFR gene entered medical genetics through studies in the early 1990s on how cells respond to leukemia inhibitory factor, a signaling protein already known to affect growth and development. Researchers soon recognized that the receptor was part of a broader family of cell signaling genes, which helped place it in a larger biological context. From these first observations, research expanded steadily. A major milestone came in 2004, when pathogenic variants in the LIFR gene were linked to Stüve-Wiedemann syndrome, giving a clear genetic explanation for a condition that had previously been defined mainly by clinical features. That discovery helped connect lab research with patient care and deepened interest in this gene’s role in early development.